These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED:
JUNE 30,
2025
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File No.
1-33145
SALLY BEAUTY HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware
36-2257936
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
3001 Colorado Boulevard
Denton
,
Texas
76210
(Address of principal executive offices)
(Zip Code)
(
800
)
777-5706
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, $0.01 par value
SBH
The New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
Number of shares of common stock outstanding as of July 31, 2025:
98,944,792
.
In this Quarterly Report, references to the "Company,” “Sally Beauty,” “our company,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.
Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein that are not purely historical facts or that depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would,” or similar expressions may also identify such forward-looking statements.
Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors that could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024, which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.
The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.
3
PART I — FINANCI
AL INFORMATION
Item 1. Financi
al Statements.
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Ba
lance Sheets
(In thousands, except par value data)
June 30,
2025
September 30,
2024
(Unaudited)
Assets
Current assets:
Cash and cash equivalents
$
112,800
$
107,961
Trade accounts receivable, net
29,743
33,635
Accounts receivable, other
66,214
58,553
Inventory
1,005,365
1,036,624
Other current assets
47,522
68,541
Total current assets
1,261,644
1,305,314
Property and equipment, net of accumulated depreciation of $
923,072
at
June 30, 2025, and $
881,818
at September 30, 2024
256,472
269,872
Operating lease assets
589,960
582,573
Goodwill
540,985
538,266
Intangible assets, excluding goodwill, net of accumulated amortization of
$
23,010
at June 30, 2025, and $
33,761
at September 30, 2024
56,180
59,960
Other assets
38,859
36,914
Total assets
$
2,744,100
$
2,792,899
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt
$
4,000
$
4,127
Accounts payable
193,040
269,424
Accrued liabilities
165,291
162,950
Current operating lease liabilities
155,591
136,068
Income taxes payable
5,920
20,100
Total current liabilities
523,842
592,669
Long-term debt
882,383
978,255
Long-term operating lease liabilities
468,998
479,616
Other liabilities
20,874
22,066
Deferred income tax liabilities, net
85,094
91,758
Total liabilities
1,981,191
2,164,364
Stockholders’ equity:
Common stock, $
0.01
par value. Authorized
500,000
shares;
99,438
and
101,854
shares issued and shares outstanding at June 30, 2025, and
September 30, 2024, respectively
994
1,019
Preferred stock, $
0.01
par value. Authorized
50,000
shares;
no
ne issued
—
—
Accumulated earnings
863,251
740,685
Accumulated other comprehensive loss, net of tax
(
101,336
)
(
113,169
)
Total stockholders’ equity
762,909
628,535
Total liabilities and stockholders’ equity
$
2,744,100
$
2,792,899
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Stateme
nts of Earnings
(In thousands, except per share data)
(Unaudited)
Three Months Ended
Nine Months Ended
June 30,
June 30,
2025
2024
2025
2024
Net sales
$
933,307
$
942,340
$
2,754,348
$
2,782,003
Cost of goods sold
452,322
461,457
1,337,706
1,370,872
Gross profit
480,985
480,883
1,416,642
1,411,131
Selling, general and administrative expenses
402,812
408,730
1,168,776
1,210,303
Restructuring
—
383
—
361
Operating earnings
78,173
71,770
247,866
200,467
Interest expense
15,709
20,707
49,440
58,544
Earnings before provision for income taxes
62,464
51,063
198,426
141,923
Provision for income taxes
16,740
13,339
52,479
36,565
Net earnings
$
45,724
$
37,724
$
145,947
$
105,358
Earnings per share:
Basic
$
0.46
$
0.37
$
1.44
$
1.01
Diluted
$
0.44
$
0.36
$
1.40
$
0.98
Weighted-average shares:
Basic
100,463
103,190
101,367
104,477
Diluted
103,239
105,897
104,187
107,186
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehe
nsive Income
(In thousands)
(Unaudited)
Three Months Ended
Nine Months Ended
June 30,
June 30,
2025
2024
2025
2024
Net earnings
$
45,724
$
37,724
$
145,947
$
105,358
Other comprehensive income (loss):
Foreign currency translation adjustments
27,174
(
5,955
)
11,350
1,494
Interest rate swap, net of tax
(
41
)
46
703
(
1,458
)
Foreign exchange contracts, net of tax
(
1,122
)
887
(
220
)
874
Other comprehensive income (loss), net of tax
26,011
(
5,022
)
11,833
910
Total comprehensive income
$
71,735
$
32,702
$
157,780
$
106,268
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Stockh
olders’ Equity
(In thousands)
(Unaudited)
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Accumulated
Comprehensive
Stockholders’
Shares
Amount
Capital
Earnings
Loss
Equity
Balance at September 30, 2024
101,854
$
1,019
$
—
$
740,685
$
(
113,169
)
$
628,535
Net earnings
—
—
—
61,013
—
61,013
Other comprehensive loss
—
—
—
—
(
23,981
)
(
23,981
)
Share-based compensation
—
—
6,053
—
—
6,053
Stock issued for equity awards
1,162
12
69
—
—
81
Employee withholding taxes paid
related to net share settlement
(
392
)
(
4
)
(
5,260
)
—
—
(
5,264
)
Repurchases and cancellations of
common stock
(
753
)
(
8
)
(
862
)
(
9,078
)
—
(
9,948
)
Balance at December 31, 2024
101,871
$
1,019
$
—
$
792,620
$
(
137,150
)
$
656,489
Net earnings
—
—
—
39,210
—
39,210
Other comprehensive income
—
—
—
—
9,803
9,803
Share-based compensation
—
—
4,238
—
—
4,238
Stock issued for equity awards
112
1
321
—
—
322
Employee withholding taxes paid
related to net share settlement
(
1
)
—
(
7
)
—
—
(
7
)
Repurchases and cancellations of
common stock
(
1,088
)
(
11
)
(
4,552
)
(
5,676
)
—
(
10,239
)
Balance at March 31, 2025
100,894
$
1,009
$
—
$
826,154
$
(
127,347
)
$
699,816
Net earnings
—
—
—
45,724
—
45,724
Other comprehensive income
—
—
—
—
26,011
26,011
Share-based compensation
—
—
4,509
—
—
4,509
Repurchases and cancellations of
common stock
(
1,456
)
(
15
)
(
4,509
)
(
8,627
)
—
(
13,151
)
Balance at June 30, 2025
99,438
$
994
$
—
$
863,251
$
(
101,336
)
$
762,909
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Accumulated
Comprehensive
Stockholders’
Shares
Amount
Capital
Earnings
Loss
Equity
Balance at September 30, 2023
106,266
$
1,063
$
5,677
$
624,772
$
(
122,764
)
$
508,748
Net earnings
—
—
—
38,390
—
38,390
Other comprehensive income
—
—
—
—
10,808
10,808
Share-based compensation
—
—
5,118
—
—
5,118
Stock issued for equity awards
722
7
209
—
—
216
Employee withholding taxes paid
related to net share settlement
(
192
)
(
2
)
(
1,738
)
—
—
(
1,740
)
Repurchases and cancellations of
common stock
(
1,939
)
(
19
)
(
9,266
)
(
10,915
)
—
(
20,200
)
Balance at December 31, 2023
104,857
$
1,049
$
—
$
652,247
$
(
111,956
)
$
541,340
Net earnings
—
—
—
29,244
—
29,244
Other comprehensive loss
—
—
—
—
(
4,876
)
(
4,876
)
Share-based compensation
—
—
3,964
—
—
3,964
Stock issued for equity awards
184
2
1,396
—
—
1,398
Employee withholding taxes paid
related to net share settlement
(
1
)
(
1
)
(
19
)
—
—
(
20
)
Repurchases and cancellations of
common stock
(
1,526
)
(
15
)
(
5,341
)
(
14,844
)
—
(
20,200
)
Balance at March 31, 2024
103,514
$
1,035
$
—
$
666,647
$
(
116,832
)
$
550,850
Net earnings
—
—
—
37,724
—
37,724
Other comprehensive loss
—
—
—
—
(
5,022
)
(
5,022
)
Share-based compensation
—
—
4,178
—
—
4,178
Stock issued for equity awards
5
—
40
—
—
40
Repurchases and cancellations of
common stock
(
876
)
(
9
)
(
4,218
)
(
5,873
)
—
(
10,100
)
Balance at June 30, 2024
102,643
$
1,026
$
—
$
698,498
$
(
121,854
)
$
577,670
The accompanying notes are an integral part of these condensed consolidated financial statements.
7
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of C
ash Flows
(In thousands)
(Unaudited)
Nine Months Ended June 30,
2025
2024
Cash Flows from Operating Activities:
Net earnings
$
145,947
$
105,358
Adjustments to reconcile net earnings to net cash provided
by operating activities:
Depreciation and amortization
75,593
83,533
Share-based compensation expense
14,800
13,260
Amortization of deferred financing costs
1,609
1,872
Loss on early extinguishment of debt
943
3,734
Impairment of long-lived assets
3,222
626
Loss (gain) on disposal of equipment and other property
(
26,641
)
4
Gain on divestiture of subsidiary
(
768
)
—
Deferred income taxes
(
6,846
)
(
6,509
)
Changes in (exclusive of effects of acquisitions):
Trade accounts receivable
4,028
815
Accounts receivable, other
(
6,836
)
(
15,954
)
Inventory
34,193
(
46,716
)
Other current assets
3,954
2,914
Other assets
506
(
445
)
Operating leases, net
(
10
)
(
2,421
)
Accounts payable and accrued liabilities
(
74,571
)
(
13,615
)
Income taxes payable
(
14,120
)
11,158
Other liabilities
(
1,051
)
(
1,759
)
Net cash provided by operating activities
153,952
135,855
Cash Flows from Investing Activities:
Payments for property and equipment
(
59,271
)
(
63,808
)
Proceeds from sale of property and equipment, net
43,574
—
Proceeds from divestiture of subsidiary
3,128
—
Acquisitions, net of cash acquired
(
371
)
(
218
)
Net cash used by investing activities
(
12,940
)
(
64,026
)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt and ABL Facility
466,000
1,345,458
Repayments of long-term debt and ABL Facility
(
564,122
)
(
1,383,553
)
Debt issuance costs
(
1,535
)
(
9,135
)
Proceeds from equity awards
403
1,654
Payments for common stock repurchased
(
33,338
)
(
50,500
)
Employee withholding taxes paid related to net share settlement of equity awards
(
5,271
)
(
1,759
)
Net cash used by financing activities
(
137,863
)
(
97,835
)
Effect of foreign exchange rate changes on cash and cash equivalents
1,690
380
Net increase (decrease) in cash and cash equivalents
4,839
(
25,626
)
Cash and cash equivalents, beginning of period
107,961
123,001
Cash and cash equivalents, end of period
$
112,800
$
97,375
Supplemental Cash Flow Information:
Interest paid
$
38,769
$
56,498
Income taxes paid
$
75,391
$
34,477
Capital expenditures incurred but not paid
$
8,480
$
9,970
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
Sally Beauty Holdings, Inc. and Subsidiaries
Notes to Condensed Cons
olidated Financial Statements
(Unaudited)
1. Significant Accounting Policies
Basis of Presentation
The unaudited condensed consolidated interim financial statements of Sally Beauty Holdings, Inc. and its subsidiaries included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024. In the opinion of management, these unaudited condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and that are necessary to present fairly our consolidated financial position as of June 30, 2025, and September 30, 2024, our consolidated results of operations, consolidated comprehensive income, consolidated statements of stockholders’ equity for the three and nine months ended June 30, 2025 and 2024, and consolidated cash flows for the nine months ended June 30, 2025 and 2024
.
Principles of Consolidation
The unaudited condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All amounts are presented in U.S. Dollars.
Accounting Policies
We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.
Use of Estimates
In order to present our condensed consolidated interim financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable assumptions available at the time of preparation; however, actual results could differ due to changes in facts and circumstances. Significant estimates and assumptions are involved in the accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangible assets and goodwill, and other reserves. We believe these estimates and assumptions are reasonable based on management’s knowledge of current events and anticipated future actions, and changes in facts and circumstances may result in revised estimates and impact actual results. Revisions to estimates are recognized in the period in which the facts that give rise to the change become known.
2. Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) No. 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
, to enhance segment disclosures for annual and interim consolidated financial statements, including significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”). The amendments in the update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The new standard is not expected to have a material impact on our consolidated financial statements; however, we expect to provide additional detail and disclosures upon adoption.
In December 2023, the FASB issued ASU No. 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures
, to expand disclosures in an entity’s income tax rate reconciliation table and the disaggregation of taxes paid in U.S. and foreign jurisdictions. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this update, but we do not expect the update to impact our consolidated results of operations or financial position.
In November 2024, the FASB issued ASU 2024-03,
Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40)
, which requires, among other things, more detailed disclosure about types of expenses in commonly presented expense captions such as cost of goods sold and selling, general and administrative expenses. The update is intended to improve disclosures by providing amounts related to inventory purchases, employee compensation, depreciation, and amortization. The amendments in this update are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal
9
years beginning after December 15, 2027.
Early adoption is permitted, but we currently do not expect to early adopt this standard. We are currently evaluating the impact of this update to our consolidated financial statements and disclosures.
3. Revenue Recognition
Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale in our stores or when products are shipped for e-commerce orders. Revenue is recognized, net of estimated sales returns and sales taxes, when control of the merchandise is transferred to the customer. We estimate sales returns based on historical data.
Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, were as follows (in thousands):
Nine Months Ended June 30,
2025
2024
Beginning Balance
$
11,493
$
14,038
Loyalty points and gift cards issued but not redeemed, net of estimated breakage
5,904
9,266
Revenue recognized from beginning liability
(
6,703
)
(
11,252
)
Ending Balance
$
10,694
$
12,052
See Note 12,
Segment Reporting
, for additional information regarding the disaggregation of our sales revenue.
4. Fair Value Measurements
We measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC Topic 820,
Fair Value Measurement
, as amended (“ASC 820”). We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs used in the valuation of an asset or liability on the measurement date.
The three levels of that hierarchy are defined as follows:
Level 1 - Quoted prices are available in active markets for identical assets or liabilities;
Level 2 - Pricing inputs are other than quoted prices in active markets, included in Level 1, that are either directly or indirectly observable; and
Level 3 - Unobservable pricing inputs in which little or no market activity exists, therefore requiring an entity to develop its own model with estimates and assumptions.
Financial instruments measured at fair value on recurring basis
Consistent with the fair value hierarchy, we categorized our financial assets and liabilities as follows:
(in thousands)
Classification
Fair Value Hierarchy Level
June 30,
2025
September 30,
2024
Financial Assets:
Foreign exchange contracts
Designated cash flow hedges
Other current assets
Level 2
$
40
$
—
Non-designated cash flow hedges
Other current assets
Level 2
461
1,207
Interest rate swap
Other assets
Level 2
311
—
Total assets
$
812
$
1,207
.
Financial Liabilities:
Foreign exchange contracts
Designated cash flow hedges
Accrued liabilities
Level 2
$
338
$
—
Non-designated cash flow hedges
Accrued liabilities
Level 2
1,619
1,485
Interest rate swap
Other Liabilities
Level 2
—
635
Total liabilities
$
1,957
$
2,120
The fair value of each asset and liability was determined using widely accepted valuation techniques, including discounted cash flow analyses and observable inputs such as market interest rates and foreign exchange rates.
10
Other fair value disclosures
The carrying amounts, if any, of cash equivalents, trade and other accounts receivable, accounts payable, and borrowings under our $
500
million asset-based senior secured loan facility (the “ABL Facility”) approximate their respective fair values due to the short-term nature of these financial instruments. The carrying amounts and corresponding estimated fair values of our long-term debt, excluding finance lease obligations, debt issuance costs, and original issue discounts, are as follows:
The fair value of our senior notes was determined using unadjusted quoted market prices. The fair value of our Term Loan B agreement was determined using unadjusted quoted market prices for similar debt securities in active markets.
5. Stockholders’ Equity
Share Repurchases
In August 2017, our Board of Directors (the “Board”) approved a share repurchase program authorizing us to repurchase up to $
1.0
billion of our common stock, subject to certain limitations governed by our debt agreements. In 2021, our Board approved a term extension of our share repurchase program through
September 30, 2025
.
On May 6, 2025, the Board approved a term extension of the share repurchase program for an additional
four-year
period ending
September 30, 2029
. Under this extension the Company is authorized to purchase its common stock up to the amount remaining under the Board’s 2017 authorization.
As of June 30, 2025, we had approximately
$
487.8
million
of additional share repurchase authorizations remaining under our share repurchase program. For the three and nine months ended June 30, 2025
, we repurchased
1.5
million shares and
3.3
million shares of our common stock at a total cost of $
13.0
million and $
33.0
million, respectively, excluding the impact of excise taxes. For the
three and nine months ended June 30, 2024
, we repurchased
0.9
million shares and
4.3
million shares of our common stock at a total cost of $
10.0
million and $
50.0
million, respectively, excluding the impact of excise taxes.
Accumulated Other Comprehensive Loss
The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):
Foreign Currency Translation Adjustments
Interest Rate Swap
Foreign Exchange Contracts
Total
Balance at September 30, 2024
$
(
112,409
)
$
(
431
)
$
(
329
)
$
(
113,169
)
Other comprehensive income (loss) before
reclassification, net of tax
11,350
1,545
322
13,217
Reclassification to net earnings, net of tax
—
(
842
)
(
542
)
(
1,384
)
Balance at June 30, 2025
$
(
101,059
)
$
272
$
(
549
)
$
(
101,336
)
The tax impacts for the changes in other comprehensive income (loss) and the reclassifications to net earnings were not material.
11
6. Weighted-Average Shares
The following table presents a reconciliation of basic and diluted weighted-average shares (in thousands):
Three Months Ended
June 30,
Nine Months Ended
June 30,
2025
2024
2025
2024
Weighted-average basic shares
100,463
103,190
101,367
104,477
Dilutive securities:
Stock option and stock award programs
2,776
2,707
2,820
2,709
Weighted-average diluted shares
103,239
105,897
104,187
107,186
Anti-dilutive options excluded from our computation of diluted shares
1,840
1,678
1,499
1,678
7. Property and Equipment, Net and Divesture of Subsidiary
During the nine months ended June 30, 2025
, we sold our corporate headquarters located in Denton, Texas, to Denton County, Texas, for $
45.5
million, excluding $
1.5
million in closing costs.
As of September 30, 2024, the assets included in the sale were classified as held for sale within other current assets on our condensed consolidated balance sheet. As a result of the sale, we recognized a gain of approximately $
26.6
million within selling, general and administrative expenses in our condensed consolidated statements of earnings. Concurrent with the sale, we entered into a lease agreement with Denton County to lease back the property at a monthly rent of $
35,000
for a term of
twelve months
, with the option to extend the term for an additional
three months
.
On April 1, 2025, we sold
100
% of the outstanding shares of our wholly owned subsidiary, Pro-Duo Spain SL, to an unaffiliated third party for $
3.2
million. As part of the transaction, we divested operations of
19
stores in Spain and recognized a gain of $
0.8
million, recorded within selling, general, and administrative expenses in our condensed consolidated results of operations. We do not expect the sale to have a material impact on our consolidated financial position or results of operations.
8. Goodwill and Intangible Assets
During the three months ended March 31, 2025, we completed our annual impairment
assessments for goodwill and indefinite-lived intangible assets. For our goodwill testing, we performed a qualitative analysis and determined that there was no indication of impairment requiring further quantitative testing. For our indefinite-lived intangible asset assessment, we performed a quantitative analysis and determined a trade name within the SBS reporting segment, as defined below, was fully impaired. As a result, we recognized an impairment loss of $
1.8
million within selling, general, and administrative expenses. No material impairment losses were recognized in the prior periods presented in connection with our goodwill and intangible assets.
Goodwill allocated to our Sally Beauty Supply ("SBS") and Beauty Systems Group ("BSG") reporting units, which are also defined as our SBS and BSG segments, was
$
91.1
million
and
$
449.8
million
, respectively, as of June 30, 2025.
Three Months Ended
June 30,
Nine Months Ended
June 30,
(in thousands)
2025
2024
2025
2024
Intangible assets amortization expense
$
851
$
764
$
2,550
$
2,415
For the nine months ended June 30, 2025
, changes in goodwill reflect the effects of foreign currency translation adjustments of $
2.5
million and purchase accounting adjustments of $
0.4
million related to the finalization of the fair value assessment for our acquisition of Exclusive Beauty
Supply, Inc, partially offset by a reduction of $
0.2
million in conjunction with the sale of Pro-Duo Spain SL
. Additionally, changes to other intangibles include the effects of foreign currency translation adjustments of $
0.5
million.
12
9. Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
June 30,
2025
September 30,
2024
Compensation and benefits
$
61,481
$
76,649
Deferred revenue
15,829
16,080
Interest payable
14,034
4,108
Accrued freight
11,064
8,240
Rental obligations
10,676
11,039
Insurance reserves
8,084
7,526
Operating accruals and other
44,123
39,308
Total accrued liabilities
$
165,291
$
162,950
10. Short-term and Long-term Debt
In December 2024, the Company and other parties to the ABL Facility entered into a fifth amendment, which, among other things, extended the maturity date to
December 11, 2029
, modified certain covenant provisions, and increased the commitment fee to
0.25
% from
0.20
%. At
June 30, 2025
, there were
no
outstanding borrowings under our ABL Facility, and we ha
d $
482.5
million
available for borrowing, including under our Canadian sub-facility, subject to a borrowing base limitation, as reduced by outstanding letters of credit. In connection with the amendment, we incurred approximately $
1.5
million in debt issuance costs that are being amortized over the remaining life of the ABL Facility.
Additionally, during the three months ended December 31, 2024, March 31, 2025, and June 30, 2025, we voluntarily repaid $
40.0
million, $
35.0
million, and $
20.0
million, respectively, of outstanding Term Loan B principle in addition to our mandatory quarterly payments. In connection with the repayments, we recognized a $
0.9
million loss on debt extinguishment within interest expense related to unamortized debt issuance costs for the
nine months ended June 30, 2025
.
11. Derivative Instruments and Hedging Activities
During the nine months ended June 30, 2025
, we did
no
t purchase or hold any derivative instruments for trading or speculative purposes. See Note
4,
Fair Value Measurements
, for the classification and fair value of our derivative instruments.
Designated Cash Flow Hedges
Foreign Currency Forwards
We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on forecasted inventory purchases in U.S. dollars by our foreign subsidiaries.
At
June 30, 2025, we held forwards, which expire ratably through September 30, 2025, with a notional amount, based upon exchange rates at June 30, 2025
, as follows (in thousands):
Notional Currency
Notional Amount
Mexican Peso
$
6,113
Canadian Dollar
3,300
Euro
1,738
Total
$
11,151
The changes in fair value related to these foreign currency forwards are recorded quarterly into AOCL. As the forwards are exercised, the realized gains or losses are recognized into cost of goods sold (“COGS”), based on inventory turns, in our condensed consolidated statements of earnings. For the three months ended June 30, 2025 and 2024, we recognized net gains of
$
0.6
million
and net losses of
$
0.4
million
, respectively. For the nine months ended June 30, 2025 and 2024, we recognized net gains of
$
0.7
million
and net losses of
$
2.5
million
, respectively. Based on June 30, 2025
, valuations and exchange rates, we expect to reclassify approximately $
0.4
million of net losses from AOCL into COGS over the next 12 months.
13
Interest Rate Swap
In April 2023, we entered into a
three-year
interest rate swap agreement with an initial notional amount of $
200
million (the “Interest Rate Swap”) to mitigate the exposure to higher interest rates in connection with our Term Loan B due in 2030. The Interest Rate Swap involves fixed monthly payments at the contract rate of
3.705
%, and in return, we will receive a floating interest payment based on the 1-month Adjusted Term SOFR Rate. The Interest Rate Swap will mature in
April 2026
and is designated as a cash flow hedge. Changes in the fair value of the Interest Rate Swap are recorded quarterly, net of income tax, and included in AOCL.
Each month, we recognize either income or expense, based on the position of the interest rates, into interest expense on our condensed consolidated statements of earnings related to the Interest Rate Swap. For the three months ended June 30, 2025 and 2024, we recognized income of
$
0.2
million
and
$
0.8
million
, respectively. For the nine months ended June 30, 2025 and 2024, we recognized income of
$
1.1
million
and
$
2.5
million
, respectively. At June 30, 2025
, based on current at interest rates and the fair value of the Interest Rate Swap, we expect to reclassify approximately $
0.3
million of net gains from AOCL into interest expense over the next 12 months.
Non-Designated Derivative Instruments
We also enter into foreign exchange forward contracts to mitigate our exposure to exchange rate fluctuations related to certain intercompany balances that are not considered permanently invested.
At
June 30, 2025, we held forward contracts, which mature at various dates during the first month of each of the next two fiscal quarters, with a notional amount, based upon exchange rates at June 30, 2025
, as follows (in thousands):
Notional Currency
Notional Amount
British Pound
$
37,860
Euro
14,229
Canadian Dollar
11,656
Mexican Peso
7,032
Total
$
70,777
C
hanges in the fair value of the forward contracts, as well as realized gains or losses upon settlement, are recorded in selling, general and administrative expenses. For the
three months ended June 30, 2025 and 2024, we recognized net losses of
$
1.3
million
and net gains of
$
0.8
million
, respectively, related to the foreign exchange forward contracts. For the nine months ended June 30, 2025 and 2024, we recognized net losses of
$
0.3
million
and
$
0.8
million
, respectively, related to the foreign exchange forward contracts.
12. Segment Reporting
Segment data for the
three and nine months ended June 30, 2025 and 2024, is as follows (in thousands):
Three Months Ended
June 30,
Nine Months Ended
June 30,
2025
2024
2025
2024
Net sales:
SBS
$
526,782
$
536,536
$
1,552,803
$
1,573,015
BSG
406,525
405,804
1,201,545
1,208,988
Total
$
933,307
$
942,340
$
2,754,348
$
2,782,003
Earnings before provision for income taxes:
Segment operating earnings:
SBS
$
83,305
$
86,938
$
240,484
$
241,387
BSG
50,672
46,753
145,075
134,395
Segment operating earnings
133,977
133,691
385,559
375,782
Unallocated expenses
(a)
55,804
61,538
137,693
174,954
Restructuring
—
383
—
361
Consolidated operating earnings
78,173
71,770
247,866
200,467
Interest expense
15,709
20,707
49,440
58,544
Earnings before provision for income taxes
$
62,464
$
51,063
$
198,426
$
141,923
(a)
Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. For the nine months ended June 30, 2025
, unallocated expenses include a $
26.6
million gain from the sale of our corporate headquarters. See
Note 7,
Property and Equipment, Net
,
for more information.
Sales between segments, which are eliminated in consolidation, were not material during the three and nine months ended June 30, 2025 and 2024.
14
Disaggregation of net sales by segment
Periodically, we make minor adjustments to our product hierarchy, which impacts the roll-up of our merchandise categories. As a result, certain prior year amounts have been reclassified to conform to current year presentation. The following tables disaggregate our segment revenues by merchandise category.
Three Months Ended
June 30,
Nine Months Ended
June 30,
SBS
2025
2024
2025
2024
Hair color
42.9
%
40.6
%
41.9
%
39.7
%
Hair care
23.0
%
24.2
%
23.5
%
24.5
%
Styling tools and supplies
16.2
%
16.2
%
16.9
%
17.1
%
Nail
10.2
%
10.5
%
10.0
%
10.2
%
Skin and cosmetics
7.5
%
8.1
%
7.5
%
8.0
%
Other beauty items
0.2
%
0.4
%
0.2
%
0.5
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
Three Months Ended
June 30,
Nine Months Ended
June 30,
BSG
2025
2024
2025
2024
Hair color
43.0
%
41.8
%
41.9
%
40.9
%
Hair care
41.6
%
41.7
%
41.8
%
42.1
%
Styling tools and supplies
9.9
%
10.3
%
10.4
%
10.5
%
Skin and cosmetics
3.2
%
3.4
%
3.5
%
3.7
%
Nail
2.2
%
2.5
%
2.3
%
2.4
%
Other beauty items
0.1
%
0.3
%
0.1
%
0.4
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
The following tables disaggregate our segment revenue by sales channels:
Three Months Ended
June 30,
Nine Months Ended
June 30,
SBS
2025
2024
2025
2024
Company-operated stores
91.8
%
93.0
%
91.9
%
93.2
%
E-commerce
8.2
%
7.0
%
8.1
%
6.8
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
Three Months Ended
June 30,
Nine Months Ended
June 30,
BSG
2025
2024
2025
2024
Company-operated stores
69.5
%
68.5
%
69.4
%
68.3
%
E-commerce
13.7
%
13.4
%
13.9
%
13.7
%
Distributor sales consultants
9.2
%
10.7
%
9.4
%
10.6
%
Franchise stores
7.6
%
7.4
%
7.3
%
7.4
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
15
Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations
This section discusses management’s view of the financial condition, results of operations and cash flows of Sally Beauty for the periods covered by this Quarterly Report. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2024, including the Risk Factors sections therein, as well as the condensed consolidated interim financial statements and accompanying notes included elsewhere in this Quarterly Report.
Financial Summary for the Three Months Ended June 30, 2025
•
Consolidated net sales for the three months ended June 30, 2025, decreased $9.0 million, or 1.0%, to $933.3 million, compared to the three months ended June 30, 2024;
•
Consolidated comparable sales decreased 0.4% for the three months ended June 30, 2025;
•
Consolidated gross profit for the three months ended June 30, 2025, was relatively flat at $481.0 million, compared to the three months ended June 30, 2024. Consolidated gross margin increased 50 bps to 51.5% for the three months ended June 30, 2025, compared to the three months ended June 30, 2024;
•
Consolidated operating earnings for the three months ended June 30, 2025, increased $6.4 million, or 8.9%, to $78.2 million, compared to the three months ended June 30, 2024. Operating margin increased 80 bps to 8.4% for the three months ended June 30, 2025, compared to the three months ended June 30, 2024;
•
For the three months ended June 30, 2025, our consolidated net earnings increased $8.0 million, or 21.2%, to $45.7 million, compared to the three months ended June 30, 2024;
•
For the three months ended June 30, 2025, our diluted earnings per share was $0.44 compared to $0.36 for the three months ended June 30, 2024; and
•
Cash provided by operations was $69.4 million for the three months ended June 30, 2025, compared to $47.9 million for the three months ended June 30, 2024.
Comparable Sales
We consider comparable sales to be an appropriate performance indicator to measure our sales growth compared to the prior period. O
ur comparable sales metric includes sales from stores that have been operating for 14 months or longer as of the end of the reporting period, as well as sales from e-commerce revenue, sales to franchisees, and full service sales. Our comparable sales metric excludes the impact of foreign exchange rate fluctuations and sales from stores relocated until 14 months after the relocation. Similarly, revenue from acquired stores is excluded from our comparable sales metric until 14 months after the acquisition.
Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.
16
Overview
Key Operating Metrics
The following table sets forth, for the periods indicated, information concerning key measures on which we rely to evaluate our operating performance (dollars in thousands):
Three Months Ended June 30,
Nine Months Ended June 30,
2025
2024
Increase (Decrease)
2025
2024
Increase (Decrease)
Net sales:
SBS
$
526,782
$
536,536
$
(9,754
)
(1.8
)%
$
1,552,803
$
1,573,015
$
(20,212
)
(1.3
)%
BSG
406,525
405,804
721
0.2
%
1,201,545
1,208,988
(7,443
)
(0.6
)%
Consolidated
$
933,307
$
942,340
$
(9,033
)
(1.0
)%
$
2,754,348
$
2,782,003
$
(27,655
)
(1.0
)%
Gross profit:
SBS
$
320,866
$
321,051
$
(185
)
(0.1
)%
$
940,519
$
935,189
$
5,330
0.6
%
BSG
160,119
159,832
287
0.2
%
476,123
475,942
181
0.0
%
Consolidated
$
480,985
$
480,883
$
102
0.0
%
$
1,416,642
$
1,411,131
$
5,511
0.4
%
Segment gross margin:
SBS
60.9
%
59.8
%
110
bps
60.6
%
59.5
%
110
bps
BSG
39.4
%
39.4
%
—
bps
39.6
%
39.4
%
20
bps
Consolidated
51.5
%
51.0
%
50
bps
51.4
%
50.7
%
70
bps
Net earnings:
Segment operating earnings:
SBS
$
83,305
$
86,938
$
(3,633
)
(4.2
)%
$
240,484
$
241,387
$
(903
)
(0.4
)%
BSG
50,672
46,753
3,919
8.4
%
145,075
134,395
10,680
7.9
%
Segment operating earnings
133,977
133,691
286
0.2
%
385,559
375,782
9,777
2.6
%
Unallocated expenses and restructuring
(a)
55,804
61,921
(6,117
)
(9.9
)%
137,693
175,315
(37,622
)
(21.5
)%
Consolidated operating earnings
78,173
71,770
6,403
8.9
%
247,866
200,467
47,399
23.6
%
Interest expense
15,709
20,707
(4,998
)
(24.1
)%
49,440
58,544
(9,104
)
(15.6
)%
Earnings before provision for income taxes
62,464
51,063
11,401
22.3
%
198,426
141,923
56,503
39.8
%
Provision for income taxes
16,740
13,339
3,401
25.5
%
52,479
36,565
15,914
43.5
%
Net earnings
$
45,724
$
37,724
$
8,000
21.2
%
$
145,947
$
105,358
$
40,589
38.5
%
.
Comparable sales growth (decline):
SBS
(1.1
)%
0.7
%
(180)
bps
0.1
%
(1.7
)%
180
bps
BSG
0.5
%
2.6
%
(210)
bps
(0.2
)%
1.8
%
(200)
bps
Consolidated
(0.4
)%
1.5
%
(190)
bps
—
(0.2
)%
20
bps
Number of stores at end-of-period (including franchises):
SBS
3,096
3,128
(32
)
(1.0
)%
BSG
1,329
1,332
(3
)
(0.2
)%
Consolidated
4,425
4,460
(35
)
(0.8
)%
(a)
Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings. Additionally, unallocated expenses include costs associated with our Fuel for Growth initiative as well as the $26.6 gain related to the sale of our corporate headquarters during the nine months ended June 30, 2025. See Note 7,
Property and Equipment, Net
, for more information related to the sale of our corporate headquarters.
17
Results of Operations
The Three Months Ended June 30, 2025, compared to the Three Months Ended June 30, 2024
Net Sales
SBS
.
The decrease in net sales for SBS was primarily driven by the following (in thousands):
Comparable sales
$
(5,929
)
Sales outside comparable sales
(a)
(4,222
)
Foreign currency exchange
397
Total
$
(9,754
)
(a)
Includes closed stores, net of stores opened for less than 14 months.
SBS’s net sales decrease was driven primarily by lower comparable sales and the impacts of net store closures over the past 12 months. The decrease in comparable sales was primarily a result of macro uncertainty, which impacted consumer spending, partially offset by strong growth in hair color and digital marketplaces.
BSG
.
The increase in net sales for BSG was primarily driven by the following (in thousands):
Comparable sales
$
2,089
Sales outside comparable sales
(a)
(989
)
Foreign currency exchange
(379
)
Total
$
721
(a)
Includes closed stores, net of stores opened for less than 14 months and sales from acquired stores.
BSG’s net sales increase was primarily from higher comparable sales resulting from continued momentum from expanded distribution and new brand innovation, partially offset by the impacts of net store closures over the past 12 months.
Gross Profit
SBS
.
SBS’s gross profit was relatively flat for the three months ended June 30, 2025, as a result of lower net sales, partially offset by a higher gross margin. SBS’s gross margin improvement was driven primarily by higher product margins resulting from benefits from our Fuel for Growth initiative, lower distribution and freight costs, and lower shrink expense, partially offset by an inventory write-off in our European operations in connection with our Fuel for Growth initiative.
BSG
.
BSG’s gross profit was relatively flat for the three months ended June 30, 2025, as a result of slightly higher net sales, while gross margin was unchanged. BSG’s gross margin was flat to last year, but included lower distribution and freight costs, offset by lower product margins related to brand mix.
Selling, General and Administrative Expenses
SBS
.
SBS’s selling, general and administrative expenses increased $3.4 million, or 1.5%, for the three months ended June 30, 2025, and included a favorable impact from foreign exchange rates of $4.0 million. As a percentage of SBS net sales, selling, general and administrative expenses for the three months ended June 30, 2025, were 45.1%, compared to 43.6% for the three months ended June 30, 2024. The increase as a percentage of sales was primarily due to deleveraging resulting from lower net sales and an increase in labor and other compensation-related expenses.
BSG
.
BSG’s selling, general and administrative expenses decreased $3.6 million, or 3.2%, for the three months ended June 30, 2025. As a percentage of BSG net sales, selling, general and administrative expenses for the three months ended June 30, 2025, were 26.9% compared to 27.9% for the three months ended June 30, 2024. The decrease as a percentage of sales was primarily due to decreases in depreciation expense and delivery expense.
Unallocated.
Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, decreased $5.7 million, or 9.3%, for the three months ended June 30, 2025, primarily due to lower costs in connection to our Fuel for Growth initiative and savings generated from this initiative, partially offset by higher information technology costs and an increase in labor and other compensation-related expenses.
Interest Expense
The decrease in interest expense was driven by a lower outstanding principle balance and interest rate on our Term Loan B, fewer borrowings on our ABL facility, and lower losses on debt extinguishment compared to the prior year.
18
Provision for Income Taxes
The effective tax rate was 26.8% and 26.1% for the three months ended June 30, 2025 and 2024, respectively. The increase in the effective tax rate was primarily due to the divestiture of Spain operations and the associated net operating losses not utilized.
In December of 2021, the Organization for Economic Cooperation and Development (OECD) established a framework, referred to as Pillar 2, designed to ensure large multinational enterprises pay a minimum 15 percent level of tax on the income arising in each jurisdiction in which they operate. The earliest effective date is for taxable years beginning after December 31, 2023, which for us is fiscal year 2025. Numerous jurisdictions in which Sally Beauty operates have enacted the OECD model rules or drafted legislation, including Belgium, Canada, France, Germany, Ireland, Italy, Netherlands, Spain, and the United Kingdom. The United States is not subject to Pillar 2. We do not expect this legislation to have a material impact on our consolidated financial statements. We will continue to monitor and evaluate new legislation and guidance, which could change our current assessment.
The Nine Months Ended June 30, 2025, compared to the Nine Months Ended June 30, 2024
Net Sales
SBS
.
The decrease in net sales for SBS was primarily driven by the following (in thousands):
Comparable sales
$
1,675
Sales outside comparable sales
(a)
(9,786
)
Foreign currency exchange
(12,101
)
Total
$
(20,212
)
(a)
Includes closed stores, net of stores opened for less than 14 months.
SBS’s net sales decrease was primarily driven by negative impacts from foreign exchange rates and net stores closed during the prior 12 months, partially offset by an increase in comparable sales. The increase in comparable sales was primarily driven by strong growth in hair color and digital marketplaces, partially offset by external factors that impacted consumer spending, including weather, an unusually harsh flu season and macro uncertainty.
BSG
.
The decrease in net sales for BSG was primarily driven by the following (in thousands):
Comparable sales
$
(2,665
)
Sales outside comparable sales
(a)
(1,532
)
Foreign currency exchange
(3,246
)
Total
$
(7,443
)
(a)
Includes closed stores, net of stores opened for less than 14 months and sales from acquired stores.
BSG’s net sales decrease reflects external factors during the fiscal year that impacted stylist purchasing behavior, including weather, an unusually harsh flu season and macro uncertainty, negative impacts from foreign exchange rates, and the impacts of net store closures over the past 12 months, partially offset by continued momentum from expanded distribution and new brand innovation.
Gross Profit
SBS
.
SBS’s gross profit increased for the nine months ended June 30, 2025, as a result of a higher gross margin, partially offset by lower net sales. SBS’s gross margin improvement was primarily driven by lower distribution and freight costs and higher product margins, resulting from enhanced promotional strategies and benefits from our Fuel for Growth initiative, partially offset by an inventory write-off in our European operations in connection with our Fuel for Growth initiative.
BSG
.
BSG’s gross profit was relatively unchanged for the nine months ended June 30, 2025, as a result of fewer net sales, partially offset by a higher gross margin. BSG’s gross margin improvement was driven by lower distribution and freight costs from supply chain efficiencies, partially offset by lower product margins related to brand mix.
Selling, General and Administrative Expenses
SBS
.
SBS’s selling, general and administrative expenses increased $6.2 million, or 0.9%, for the nine months ended June 30, 2025, and included a favorable impact from foreign exchange rates of $8.9 million. As a percentage of SBS net sales, selling, general and administrative expenses for the nine months ended June 30, 2025, were 45.1%, compared to 44.1% for the nine months ended June 30, 2024. The increase as a percentage of sales was primarily due to deleveraging resulting from lower net sales, increased labor and other compensation-related expenses and an impairment charge related to a trade name (non-cash expense of $1.8 million), partially offset by other Fuel for Growth benefits.
BSG
.
BSG’s selling, general and administrative expenses decreased $10.5 million, or 3.1%, for the nine months ended June 30, 2025. As a percentage of BSG net sales, selling, general and administrative expenses for the nine months ended June 30, 2025, were 27.6%
19
compared to 28.3% for the nine months ended June 30, 2024. The decrease as a percentage of sales was primarily due to decreases in delivery expense, depreciation expense, and savings generated from our Fuel for Growth initiative.
Unallocated.
Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, decreased $37.3 million, or 21.3%, for the nine months ended June 30, 2025, primarily due to a $26.6 million gain on the sale of our corporate headquarters and lower costs in connection to our Fuel for Growth initiative, partially offset by increased labor and other compensation-related expenses.
Interest Expense
The decrease in interest expense was driven by a lower outstanding principle balance and interest rate on our Term Loan B, a lower average outstanding balance on our ABL Facility, and lower losses on debt extinguishment compared to the prior year.
Provision for Income Taxes
The effective tax rate was 26.4% and 25.8% for the nine months ended June 30, 2025 and 2024, respectively. The increase in the effective tax rate was primarily due to foreign operations, including the divestiture of Spain operations, and higher federal tax credits in the prior year.
Liquidity and Capital Resources
Overview
Our principal sources of liquidity are cash from operations, cash and cash equivalents, and borrowings under our ABL Facility. We utilize these resources primarily to fund our operating costs, working capital requirements, capital expenditures, and scheduled debt service obligations, including interest and principal payments. Additionally, under our share repurchase program (see below for more details) we may repurchase shares of our common stock on the open market to return value to our shareholders. At June 30, 2025, we had $595.3 million of available liquidity, which includes $482.5 million available for borrowing under our ABL Facility and cash and cash equivalents of $112.8 million.
Our working capital (current assets less current liabilities) increased $25.2 million, to $737.8 million at June 30, 2025, compared to $712.6 million at September 30, 2024. The increase was primarily driven by the timing of accounts payable and income taxes payments, partially offset by lower inventory, as a result of a strategic reduction in slower moving products and the negative impacts of foreign exchange rates of $6.1 million, the disposal of assets held for sale previously included in other current assets as a result of the sale of our corporate headquarters, and the timing of lease renewals.
We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL Facility will be sufficient to fund our working capital and capital expenditure requirements over the next twelve months.
Cash Flows
Nine Months Ended June 30,
(in thousands)
2025
2024
Net cash provided by operating activities
$
153,952
$
135,855
Net cash used by investing activities
(12,940
)
(64,026
)
Net cash used by financing activities
(137,863
)
(97,835
)
Net Cash Provided by Operating Activities
The increase in cash provided by operating activities was primarily driven by lower inventory purchases and lower interest paid on our debt, partially offset by the timing of accounts payable and income tax payments, and lower cash receipts from customers.
Net Cash Used by Investing Activities
The decrease in cash used by investing activities was primarily the result of receiving $43.6 million from the sale of our corporate headquarters, lower capital expenditures as we lapped technology investments in the prior year, offset by investments in store improvements, and $3.1 million from the divesture of our operations in Spain.
Net Cash Used by Financing Activities
The increase in cash used by financing activities was primarily due to the higher net paydown of our long-term debt in the current year compared to the prior year, partially offset by fewer shares repurchased in the current year under our share repurchase program.
20
Debt and Guarantor Financial Information
At June 30, 2025, we had $896.0 million in outstanding debt principal, excluding unamortized debt issuance costs and debt discounts, in the aggregate, of $9.6 million. Our debt consists of $600.0 million in 2032 Senior Notes outstanding, and $296.0 million remaining on our Term Loan B. There were no outstanding borrowings under our ABL Facility. See Note 10,
Short-term and Long-term Debt
, in Item 1 of this quarterly report for more information on our debt.
We utilize our ABL Facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL Facility for general corporate purposes including funding of capital expenditures, acquisitions, paying down other debt and share repurchases. Amounts drawn on our ABL Facility are generally paid down with cash provided by our operating activities. During the nine months ended June 30, 2025, the weighted average interest rate on our borrowings under the ABL Facility was 7.4%.
We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.
Guarantor Financial Information
Our 2032 Senior Notes were issued by our wholly owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (together, the “Issuers”). The notes are unsecured debt instruments guaranteed by us and certain of our wholly owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability of our subsidiaries to make certain restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.
The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities have been eliminated.
The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of June 30, 2025, and September 30, 2024:
(in thousands)
June 30, 2025
September 30, 2024
Cash and cash equivalents
$
41,923
$
32,817
Inventory
$
745,712
$
781,512
Current assets
$
882,588
$
914,686
Total assets
$
2,048,655
$
2,085,179
Intercompany payable
$
14,892
$
6,939
Current liabilities
$
421,673
$
479,052
Total liabilities
$
1,785,679
$
1,951,874
The following table presents the summarized statement of earnings information for the Issuers and the Guarantors for the nine months ended June 30, 2025 (in thousands):
Net sales
$
2,228,990
Gross profit
$
1,166,591
Earnings before provision for income taxes
$
182,605
Net Earnings
$
135,873
Share Repurchase Programs
Under our current share repurchase program, we may from time to time repurchase our common stock on the open market in compliance with all SEC rules, including Rule 10b-18, and other legal requirements, and may be made in part under Rule 10b5-1 plans, which permit stock repurchases when the Company might otherwise be precluded from doing so. During the nine months ended June 30, 2025 and 2024, we repurchased 3.3 million shares and 4.3 million shares of our common stock for $33.0 million and $50.0 million, respectively, under our share repurchase program, excluding the impact of excise taxes. See Note 5,
Stockholders’ Equity
, for more information about our share repurchase program.
Contractual Obligations
Other than our debt, as discussed above, there have been no material changes outside the ordinary course of our business to our contractual obligations since September 30, 2024.
Off-Balance Sheet Financing Arrangements
At June 30, 2025, and September 30, 2024, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.
21
Critical Accounting Estimates
There have been no material changes to our critical accounting estimates or assumptions as disclosed in Item 7. "Management Discussion and Analysis of Financial Condition and Results of Operation" in Part II on our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.
Recent Accounting Pronouncements
See Note 2 of the Notes to Condensed Consolidated Financial Statements in Item 1 – “Financial Statements” in Part I – Financial Information.
U.S. Income Tax Regulations
On July 4, 2025, “The One Big Beautiful Bill Act” was signed into law. ASC Topic 740,
Income Taxes
, requires the effects of changes in tax law or rate to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the enacted legislation and the impact on its financial statements.
22
Item 3. Quantitative and Qualitat
ive Disclosures About Market Risk
As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. There have been no material changes to our market risks from those disclosed in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.
Item 4. Controls
and Procedures
Controls Evaluation and Related CEO and CFO Certifications.
Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2025. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.
Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.
Limitations on the Effectiveness of Controls.
We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.
Scope of the Controls Evaluation.
The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.
Conclusions regarding Disclosure Controls.
Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of June 30, 2025, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting.
During our most recent fiscal quarter there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
23
PART II — OTHE
R INFORMATION
Item 1. Legal
Proceedings
We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.
We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.
Item 1A. Ri
sk Factors
In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
Information regarding shares of common stock we repurchased during the quarter ended June 30, 2025, excluding the impact of excise taxes, is as follows:
Fiscal Period
Total Number of Shares Purchased
(1)
Average Price Paid per Share
(2)
Total
Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(1)
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
Apr 1 - Apr 30, 2025
—
$
—
—
$
500,792,460
May 1 - May 31, 2025
610,460
9.00
610,460
495,298,261
Jun 1 - Jun 30, 2025
845,404
8.90
845,404
487,774,455
Total this quarter
1,455,864
$
8.94
1,455,864
$
487,774,455
(1)
On May 6, 2025,, our Board approved a term extension through September 30, 2029, of our share repurchase program to repurchase up to $1.0 billion of our common stock, which was originally approved in August 2017.
(2)
The calculation of the average price paid per share includes the impact of commissions paid in connection with the shares repurchased.
Item 5. Other Information
During the quarter ended June 30, 2025
, no director or officer of the Company
adopted
,
modified
, or
terminated
any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408(a) of Regulation S-K.
The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.
104
The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025, formatted in iXBRL (contained in Exhibit 101).
* Included herewith
25
SIGNA
TURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SALLY BEAUTY HOLDINGS, INC.
(Registrant)
Date: August 5, 2025
By:
/s/ Marlo M. Cormier
Marlo M. Cormier
Senior Vice President, Chief Financial Officer
For the Registrant and as its Principal Financial Officer
Customers and Suppliers of Sally Beauty Holdings, Inc.
Beta
No Customers Found
No Suppliers Found
Bonds of Sally Beauty Holdings, Inc.
Price Graph
Price
Yield
Insider Ownership of Sally Beauty Holdings, Inc.
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of Sally Beauty Holdings, Inc.
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)